YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Serevent

Study Cites Increased Death Risk From Asthma Drugs

Jun 6, 2006 | Washington Post
Popular and long-acting asthma medicines such as Advair and Serevent pose a substantially increased risk of hospitalization and death to users...

Advair, Other Asthma Drug Get Label Alerts

Mar 6, 2006 | AP
The asthma medication Advair and a related drug will bear stronger warnings of an increased risk of death associated with one of their...

Top Asthma Drugs Get Stronger Warning

Mar 6, 2006 | KTLA News
The asthma medication Advair and Serevent will now carry the strongest warnings the FDA can require of prescription drugs.The "black-box"...

Serevent Exposes Blacks to Higher Risk of Asthma-Related Death – Study

Feb 22, 2006 | Newsinferno News Staff
A new study has found that GlaxoSmithKline’s (GSK) popular asthma drug, Serevent, (salmeterol), exposes African-American patients to a higher...

Serevent May Pose Greater Risk of Death to Blacks

Jan 13, 2006 | Newsinferno News Staff
Recently released information about a safety trial on the asthma drug Serevent indicates that blacks who took the drug were four times as likely to...

Asthma Drugs Educe FDA Worry

Nov 18, 2005 | www.thestreet.com
The Food and Drug Administration on Friday issued a public health advisory about potentially fatal side effects from two GlaxoSmithKline asthma...

Serevent, Advair, and Foradil Linked to Risk of Severe Asthma Exacerbations, Death

Nov 18, 2005 | Medscape
The U.S. Food and Drug Administration (FDA) has warned healthcare professionals regarding the increased risk of severe asthma episodes and death...

Safety Information About A Class of Asthma Drugs Known As Long-Acting Beta-2 Agonists

Oct 4, 2005 | Health Canada
Health Canada is advising Canadians of the possible increased risks of asthma-related deaths associated with the use of a class of asthma drugs known...

Serevent, To Be Examined By Experts Due To Deaths Associated With Its Use

Jul 17, 2005
Serevent, a powdered medication inhaled by asthma patients to keep their airways open, will be a focus of an FDA Pulmonary-Allergy Drugs Advisory...

FDA Orders "Black Box" Warning for Asthma Drugs

Jul 14, 2005 | www.consumeraffairs.com
The US Food and Drug Administration has cleared asthma drugs Advair and Serevent, allowing them to stay on the market as long as warning labels...

Page 2/3 [first] [prev] 1 2 3 [next] [last]

Serevent
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?

Please explain whether asthma attacks worsened after taking Serevent and whether they required hospitalization or intubation:

Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News